Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-25 @ 3:19 AM
NCT ID:
NCT06690905
Eligibility Criteria:
Inclusion Criteria:
* Adults (18 years and older)
* Patients hospitalized at Hôpital Charles-Le Moyne
* Obesity (as defined by a body mass index of ≥ 30 kg/m\^2)
* Piperacillin-tazobactam prescription initiated within last 24 hours
* Planned duration of piperacillin-tazobactam of 24 hours or more
Exclusion Criteria:
* Documented allergy to beta-lactams of the penicillin class
* Patients with renal replacement therapy (hemodialysis, peritoneal dialysis, continuous venovenous hemodiafiltration)
* Pregnancy
* History of seizures or epilepsy, active seizures or epilepsy treated with antiepileptic drug therapy
* Patients on prolonged intermittent infusion or continuous infusion of piperacillin-tazobactam before randomization
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06690905
Study Brief:
Protocol Section:
NCT06690905